Health ❯ Healthcare

Neurology

Alzheimer's Disease Dementia Neurodegenerative Diseases Cognitive Disorders Neurological Disorders Epilepsy Stroke Parkinson's Disease Brain Health Brain Disorders Migraine Movement Disorders Cognitive Health Cognitive Impairment Cognitive Decline Multiple Sclerosis Brain Injuries Diseases Memory Disorders Diagnosis Neuromuscular Disorders Nerve Function Symptoms Brain Injury Traumatic Brain Injury Neuroscience Patient Care Brain Tumors Brain Scans Genetic Disorders Pediatric Neurology Migraine Disorders Neuromuscular Diseases Neuroplasticity Seizures Neurodevelopmental Disorders Stroke Management CNS Disorders Oliver Sacks Neurological Diseases Neurologists Stroke Types Brain Function Neuropathy Vascular Dementia Stroke Recovery Neurodegenerative Disorders Neurophysiology Neurological Conditions Brain Cancer Headaches Coma Chronic Traumatic Encephalopathy Sleep Disorders Spinal Cord Injuries Chronic Migraines Stroke Symptoms Brain Abnormalities Autoimmune Diseases Types of Dementia Hearing Impairment Autism Spectrum Disorders Medical Research Clinical Trials Brain Stimulation Cerebrovascular Disorders Mental Health Frontotemporal Dementia Brain Infections Complications of Infectious Diseases Narcolepsy Myasthenia Gravis Cerebrospinal Fluid Disorders Neurorehabilitation Genetic Research Sensory Disorders Cognitive Training Neurocysticercosis Aging Motor Function Anosognosia Nerve Pain Motor Symptoms Essential Tremor Public Health Rehabilitation Neurosurgery Pain Perception Cognitive Rehabilitation Demenz Stroke Care Cognition Stroke Rehabilitation Headache Disorders Hydrocephalus Autoimmune Disorders Gene Therapy Multiple Sclerosis Treatments Meningitis Cerebral Palsy

Finger-Prick Blood Spot Test Detects Alzheimer’s Biomarkers With 86% Accuracy

Researchers say at-home, mail-in sampling could widen access to studies pending validation for any clinical role.

FDA Grants Priority Review to Axsome’s AXS-05 for Alzheimer’s Agitation, Sets April 30 PDUFA Date

Neurocrine’s Valbenazine Misses Phase 3 Goals in Dyskinetic Cerebral Palsy

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Shingles Vaccine Linked to Lower Dementia Risk and Fewer Deaths in New Analysis

FDA Approves One-Time Intrathecal Gene Therapy Itvisma for Older SMA Patients

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand

Shingles Vaccine Linked to Slower Dementia Progression and Lower Risk, Welsh Studies Find

USC Team Maps Four Hidden Neuron Layers in Mouse Hippocampal CA1

Kim Kardashian’s TV Brain Scan Draws Scientific Skepticism and Conspiracy Theories

Kim Kardashian’s TV Brain Scan Shows Reduced Frontal Activity Prompting Stress Plan

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Neurologist Says Wendy Williams Does Not Have Frontotemporal Dementia, Setting Up Guardianship Challenge

Study Finds PU.1-Low, CD28-Positive Microglia Curb Alzheimer’s Damage

BRAIN Initiative Team Releases First Cross-Species Developmental Brain Cell Atlases

Washington University Launches AI Imaging Center Led by Mark Anastasio

Long-Term Study Finds Seizure Reductions in Drug-Resistant Focal Epilepsy

Headband Optical Device Distinguishes Brain Blood Flow From Scalp in Human Study